In support of this, a recent study by Wang et al. demonstrated that removal of mutant p53 genes that had been associated with oncogenic gain-of-function properties by CRISPR/Cas9 had no effect on cancer cell growth in vitro or in vivo [64, 65]. Here, TP53 is linked to cancer.